THE National Registration Department (NRD) appreciates the views expressed in “Poser over MyKad photocopy” (The Star, June 28). For readers’ information, it is compulsory for a person to carry his/her MyKad at all times under Regulation 6 of The National Registration Act 1959 (Act 78) and Regulations. A MyKad copy cannot be regarded as a substitute for the original MyKad. Regulation 6 states that the person to whom an identity card has been issued shall, thereafter and for so long as he remains a registered or re-registered person under these Regulations, at all times carry on his person the identity card and, subject to the provisions of these Regulations, be responsible for the custody thereof. Any person who fails to comply with Regulation 6, if found guilty of the offence, shall be liable on conviction to a jail term not exceeding three years or to a minimum fine of RM3,000 and a maximum fine of RM20,000 or both as per Regulation 25 (i)(n) of the same Act. JAINISAH MOHD NOOR, Public Relations Officer, National Registration Department. Source of material
KOTA KINABALU: The Sabah Pharmaceutical Society (SPS) urges the public to bring their MyKad or equivalent identification documents (passport, army and police card) when purchasing controlled medicines in pharmacies throughout Sabah. Pharmacists now are required by law to record additional details obtained from MyKad for purchase of special category of controlled medicines on top of the usual name and address. SPS president Samsudin B Ahmad said in a statement that effective Jan 1, pseudoephedrine-containing medicines falls under this category. Most medications for the treatment of cold and flu symptoms contain pseudoephedrine. Prior to that, codeine and dextromethorphan also require patients to produce their MyKad. “Normally, only details such as name and address of patients are required to be recorded into the prescription book. However, some categories of medicines need the MyKad number. Across the board, it’s just easier to produce MyKad for all the required details,” he said. Read more . . .